Pancreatic Cancer Research

ResearcherJichi Medical UniversityActive in the last 2 years

Atsushi Kanno

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6341-5199; OpenAlex author ID A5027907983. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
72
Papers, trials and grants by year

2012: 2 papers · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 14

  1. A modified CAP-based grading system incorporating non-tubular components for prognostic stratification in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00428-026-04731-8↗
  2. Comparative Study of Pathological and Imaging Findings in High-Grade Pancreatic Intraepithelial Neoplasia: A Multicenter Analysis by the Japan Study Group on E… Co-author DOI 10.1097/mpa.0000000000002710↗
  3. Pancreatic Ductal Adenocarcinoma with Autoimmune Pancreatitis: A Case Report and Literature Review. Co-author DOI 10.2169/internalmedicine.4361-24↗
  4. Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis. Co-author DOI 10.1007/s10147-023-02317-x↗
  5. Concordance of the histological diagnosis of type 1 autoimmune pancreatitis and its distinction from pancreatic ductal adenocarcinoma with endoscopic ultrasoun… Co-author DOI 10.1007/s00428-021-03236-w↗
  6. Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors. First author DOI 10.3390/diagnostics11030562↗
  7. A Prospective Multicenter Study of Partially Covered Metal Stents in Patients Receiving Neoadjuvant Chemotherapy for Resectable and Borderline Resectable Pancr… Co-author DOI 10.5009/gnl19302↗
  8. Advances in Early Detection of Pancreatic Cancer. Co-author DOI 10.3390/diagnostics9010018↗
  9. Multicenter study of early pancreatic cancer in Japan. Co-author DOI 10.1016/j.pan.2017.11.007↗
  10. [A Case of Successful Stomach-Preserving Pancreaticoduodenectomy with Celiac Artery Resection after Neoadjuvant Chemoradiation Therapy for Pancreatic Cancer wi… Co-author PMID 28133191↗
  11. EBM-based Clinical Guidelines for Pancreatic Cancer (2013) issued by the Japan Pancreas Society: a synopsis. Co-author DOI 10.1093/jjco/hyu127↗
  12. miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin. Co-author DOI 10.1002/jcp.24280↗
  13. The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2. Co-author DOI 10.1002/jcp.22781↗
  14. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Co-author DOI 10.1158/1541-7786.mcr-11-0272↗

Closest collaborators

The 25 strongest of 72 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Noriyoshi Fukushima · 3 shared papers, 2022–2026 · strength 0.62
  2. Naoki Sano · 2 shared papers, 2025–2026 · strength 0.52
  3. Keiji Hanada · 4 shared papers, 2014–2026 · strength 0.44
  4. Masayuki Kitano · 3 shared papers, 2018–2026 · strength 0.41
  5. Toru Furukawa · 3 shared papers, 2018–2026 · strength 0.38
  6. Hironori Yamamoto · 2 shared papers, 2021–2025 · strength 0.35
  7. Mamoru Takenaka · 2 shared papers, 2018–2026 · strength 0.29
  8. Takao Ohtsuka · 2 shared papers, 2018–2026 · strength 0.29
  9. Akio Yanagisawa · 2 shared papers, 2018–2026 · strength 0.29
  10. Koji Yoshida · 2 shared papers, 2018–2026 · strength 0.29
  11. Atsushi Masamune · 5 shared papers, 2012–2019 · strength 0.28
  12. Tooru Shimosegawa · 6 shared papers, 2012–2018 · strength 0.23
  13. Yusuke Sakurai · 1 shared paper, 2025 · strength 0.23
  14. Naohiro Sata · 1 shared paper, 2025 · strength 0.23
  15. Masanobu Taguchi · 1 shared paper, 2025 · strength 0.23
  16. Yukiko Takayama · 1 shared paper, 2026 · strength 0.22
  17. Reiko Ashida · 1 shared paper, 2026 · strength 0.22
  18. Yasutaka Ishii · 1 shared paper, 2026 · strength 0.22
  19. Noboru Ideno · 1 shared paper, 2026 · strength 0.22
  20. Shujiro Yazumi · 1 shared paper, 2026 · strength 0.22
  21. Masao Tanaka · 1 shared paper, 2026 · strength 0.22
  22. Akira Kurita · 1 shared paper, 2026 · strength 0.22
  23. Akinori Shimizu · 1 shared paper, 2026 · strength 0.22
  24. Masataka Kikuyama · 2 shared papers, 2018–2019 · strength 0.19
  25. Hiroyuki Isayama · 2 shared papers, 2014–2021 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.